KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Non Operating Income: 2010-2024

Historic Non Operating Income for Emergent BioSolutions (EBS) over the last 15 years, with Dec 2024 value amounting to -$34.2 million.

  • Emergent BioSolutions' Non Operating Income fell 124.26% to -$18.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year increase of 209.16%. This contributed to the annual value of -$34.2 million for FY2024, which is 484.27% down from last year.
  • Emergent BioSolutions' Non Operating Income amounted to -$34.2 million in FY2024, which was down 484.27% from $8.9 million recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' Non Operating Income ranged from a high of $8.9 million in FY2023 and a low of -$49.0 million during FY2022.
  • Its 3-year average for Non Operating Income is -$24.8 million, with a median of -$34.2 million in 2024.
  • In the last 5 years, Emergent BioSolutions' Non Operating Income skyrocketed by 118.16% in 2023 and then crashed by 484.27% in 2024.
  • Emergent BioSolutions' Non Operating Income (Yearly) stood at -$26.6 million in 2020, then plummeted by 43.61% to -$38.2 million in 2021, then fell by 28.27% to -$49.0 million in 2022, then spiked by 118.16% to $8.9 million in 2023, then crashed by 484.27% to -$34.2 million in 2024.